Adrenal insufficiency (Q34203208)

31 July 2017

Adrenal insufficiency. (English)

1 reference

31 July 2017

Wiebke Arlt

1

0 references

Bruno Allolio

series ordinal

2

object named as

Bruno Allolio

1 reference

PubMed ID

12788587

31 July 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

31 July 2017

1 reference

31 July 2017

361

1 reference

31 July 2017

1881-1893

1 reference

31 July 2017

9372

1 reference

Eighty-six cases of Addison's disease

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

The prevalence of Addison's disease in Coventry, UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

High prevalence and increasing incidence of Addison's disease in western Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Epidemiological and clinical picture of Addison's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Positional cloning of the APECED gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

A mutation in CYP11B1 (Arg-448----His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

The pathophysiology and genetics of congenital lipoid adrenal hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

IMAGe, a new clinical association of intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Endocrine dysfunction in Kearns-Sayre syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Mitochondrial DNA deletion with Kearns Sayre syndrome in a child with Addison disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Hereditary isolated glucocorticoid deficiency is associated with abnormalities of the adrenocorticotropin receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Mutations of the ACTH receptor gene are only one cause of familial glucocorticoid deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Mutant WD-repeat protein in triple-A syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Adrenal insufficiency as the first clinical manifestation of the primary antiphospholipid antibody syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Adrenocortical function in patients with macrometastases of the adrenal gland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

The effect of o,p'-DDD on adrenal steroid replacement therapy requirements

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Influence of sedation on mortality in critically ill multiple trauma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Long-term etomidate and adrenocortical suppression.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Suramin and function of the adrenal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Addison's disease in Africa--a teaching hospital experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

A critical examination of adrenal tuberculosis and a 28-year autopsy experience of active tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Autoimmunity to steroid-producing cells and familial polyendocrine autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Lymphocytic adenohypophysitis: magnetic resonance imaging features of two new cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Secondary adrenal insufficiency associated with autoimmune disorders: a report of twenty-five cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Isolated congenital ACTH deficiency: a cleavage enzyme defect?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Mutations in PROP1 cause familial combined pituitary hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Classical pituitary apoplexy: clinical features, management and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Glucocorticoid-induced adrenal insufficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

DHEA treatment: myth or reality?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Secondary hypoadrenalism presenting with hypercalcaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

24-hour blood pressure profile in Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Regression of cardiac abnormalities after replacement therapy in Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Reduced lymphocyte beta 2-adrenoceptor density and impaired diastolic left ventricular function in patients with glucocorticoid deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Subjective health status in Norwegian patients with Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic-pituitary disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Dehydroepiandrosterone replacement in women with adrenal insufficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

A RAPID TEST OF ADRENOCORTICAL FUNCTION

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

A rational approach for assessing the hypothalamo-pituitary-adrenal axis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

21-Hydroxylase, a major autoantigen in idiopathic Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Rapid assessment of corticotropin reserve after pituitary surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin, and the comparison of this procedure with other tests of pituitary and adrenal function. II. In patients with hypothalamic or pituitary dysfunction or anorexia nerv

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Dose-response relationship between plasma ACTH and serum cortisol in the insulin-hypoglycaemia test in 25 healthy subjects and 109 patients with pituitary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Adrenocorticotrophin (ACTH) deficiency undetected by standard dynamic tests of the hypothalamic-pituitary-adrenal axis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Comparison of the short ACTH stimulation test with the insulin tolerance/glucagon test.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Single-dose metyrapone test at 06.00 h: an accurate method for assessment of pituitary-adrenal reserve

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

The short metyrapone test: comparison of the plasma ACTH response to metyrapone with the cortisol response to insulin-induced hypoglycaemia in patients with pituitary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

The insulin hypoglycaemia and overnight metyrapone tests in the assessment of the hypothalamic-pituitary-adrenal axis following pituitary surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

The insulin hypoglycaemia test for the assessment of the hypothalamic--pituitary--adrenal function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Regulation of corticotropin receptor number and messenger RNA in cultured human adrenocortical cells by corticotropin and angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Re-evaluation of the clinical value of the 30 min ACTH test in assessing the hypothalamic-pituitary-adrenocortical function.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Discordant Cortisol Response to Exogenous ACTH and Insulin-Induced Hypoglycemia in Patients with Pituitary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

The role of high- and low-dose corticotropin tests in the diagnosis of secondary adrenal insufficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Low-dose (1 microgram) adrenocorticotrophin (ACTH) stimulation as a screening test for impaired hypothalamo-pituitary-adrenal axis function: sensitivity, specificity and accuracy in comparison with the high-dose (250 microgram) test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Which patients benefit from provocative adrenal testing after transsphenoidal pituitary surgery?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Glucocorticoid replacement in pituitary surgery: guidelines for perioperative assessment and management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

An audit of the insulin-tolerance test in 255 patients with pituitary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Adrenocortical dysfunction in acute medical illness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Corticosteroid therapy in severe illness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

The dissociation of renin and aldosterone during critical illness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Spectrum of serum cortisol response to ACTH in ICU patients. Correlation with degree of illness and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Relative adrenal failure in intensive care: an identifiable problem requiring treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Cortisol response to corticotropin and survival in septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Haemodynamic improvement in refractory septic shock with cortisol replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Spectrum of CT findings in nonmalignant disease of the adrenal gland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

CT findings in addison’s disease caused by tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Cortisol production rate measurement by stable isotope dilution using gas chromatography-negative ion chemical ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Serum cortisol appearance-disappearance in adrenal insufficiency after oral cortisone acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Corticosteroid replacement therapy: twice or thrice daily?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Plasma ACTH and cortisol profiles in Addisonian patients receiving conventional substitution therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

An assessment of optimal hydrocortisone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

The assessment of glucocorticoid replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Glucocorticoid replacement therapy: are patients over treated and does it matter?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Bone mineral density in patients with treated Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Low Dose Dehydroepiandrosterone Affects Behavior in Hypopituitary Androgen-Deficient Women: A Placebo-Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Quality of self-care in patients on replacement therapy with hydrocortisone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Patients' self administration of hydrocortisone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Rectal hydrocortisone during stress in patients with adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

A double-blind study of perioperative steroid requirements in secondary adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Diurnal salivary cortisol patterns during pregnancy and after delivery: relationship to plasma corticotrophin-releasing-hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

[Therapy of adrenal cortex insufficiency]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Letter: Rifampicin and cortisone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Pharmacokinetics of aldosterone in patients with Addison's disease: effect of rifampicin treatment on glucocorticoid and mineralocorticoid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Decreased psychological well-being in adult patients with growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

Quality of life in patients with Addison's disease: effects of different cortisol replacement modes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

The influence of hydrocortisone substitution on the quality of life and parameters of bone metabolism in patients with secondary hypocortisolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913492-7

7 January 2021

10.1016/S0140-6736(03)13492-7

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

12788587